Celine Martin is Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group. CSS is a collection of Johnson & Johnson’s high-growth global MedTech businesses. This includes Acclarent, Biosense Webster, Cerenovus and Mentor, which collectively generate more than $5 billion in annual sales and employ more than 12,000 purpose-driven, high-performing individuals. These businesses harness the power of science, innovation and technology to help more than 1.2 million patients each year in the areas of Electrophysiology, Neurovascular, Ear, Nose & Throat, and Breast Reconstruction and Aesthetics.
Throughout her 25-year career at Johnson & Johnson, Celine has played a vital role in advancing the ambition of Johnson & Johnson MedTech, including developing new categories and advancing standards of care for atrial fibrillation, stroke and minimally invasive surgery. Based in Irvine, California, she also helped establish a West Coast hub for Johnson & Johnson.
Celine is a believer in life-long learning and holds an MBA from Wake Forest University and a master’s degree in marketing management from EM Normandie Business School. She has also completed several executive programs through Harvard Business School, INSEAD, and MIT Sloan School of Management.